Competition continues to rise among spine surgeons and practices as an increasing number of procedures move from hospitals toward the outpatient setting, where they can be performed at a lower cost.
The Latest
Premia Spine's Tops spinal arthroplasty system was found to be more cost-effective than a transforaminal lumbar interbody fusion, according to a study published in the Journal of Health Economics and Outcomes Research.
Orthopedic surgeons are split on the benefits and drawbacks of private equity as it grows in the specialty. Two surgeons told Becker's their thoughts on the trend.
Ronald Warnick, MD, was named program director of radiosurgery and neuro-oncology at Cincinnati-based Mayfield Brain and Spine.
New York City-based Hospital for Special Surgery is part of a multicenter trial examining the effectiveness of three disc replacement devices used for two-level symptomatic cervical disc disease.
Researchers at Icahn School of Medicine at Mount Sinai in New York City found that a bundled care program helped reduce disparities in total joint replacements for Black patients.
Two companies see record quarterly sales and five more updates from spine devicemakers in the last week:
Royal Biologics received FDA approval for its MAXX-BMC bone marrow aspirate concentration system.
New York City-based Hospital for Special Surgery is shifting its focus from anterior cruciate ligament reconstruction to restoration by using the Bear implant.
Although further research is needed to determine the safety and efficacy of regenerative procedures in the spine, the potential of many of these therapies — such as stem cells, platelet-rich plasma and bone marrow aspirate — is considerable.